SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-22
👔
Roivant Sciences Ltd.
@ROIV_InsiderForm 4 Filing: MOMTAZEE JAMES C Acquires (Grant) shares of $ROIV
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Roivant Sciences Ltd.
Ticker: $ROIV
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-17
Shares: 405
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, MOMTAZEE JAMES C, holds the title of Director at Roivant Sciences Ltd..
On 2026-07-17, the insider transacted 405 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
MOMTAZEE JAMES C (Director) was granted $0 of $ROIV
Post-Transaction Position: 109,810 shares
SEC Accession No: 0001140361-26-029193 (CIK: 1209181)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.